Price Alert

YD Bio Limited Ordinary S... (YDES)

NASDAQ: YDES · Real-Time Price · USD

18.87

0.37 (1.97%)

At close: Oct 15, 2025, 3:59 PM

18.87

0.00%

After-hours: Oct 15, 2025, 04:10 PM EDT

YD Bio Ordinary Shares Statistics

Share Statistics

YD Bio Ordinary Shares has n/a shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	9,295
FTD / Avg. Volume	7.2%

Short Selling Information

The latest short interest is 152.71K, so 0.22% of the outstanding shares have been sold short.

Short Interest	152.71K
Short % of Shares Out	0.22%
Short % of Float	1.11%
Short Ratio (days to cover)	1.26

Valuation Ratios

The PE ratio is -35.36 and the forward PE ratio is null. YD Bio Ordinary Shares's PEG ratio is 0.

PE Ratio	-35.36
Forward PE	n/a
PS Ratio	97.81
Forward PS	n/a
PB Ratio	7.57
P/FCF Ratio	-10.51
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for YD Bio Ordinary Shares.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.18, with a Debt / Equity ratio of 0.

Current Ratio	13.18
Quick Ratio	13.04
Debt / Equity	0
Debt / EBITDA	-0.02
Debt / FCF	n/a
Interest Coverage	-1893.69

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	undefined
Asset Turnover	0.07
Inventory Turnover	9.51

Taxes

Income Tax	25.08K
Effective Tax Rate	-1.81%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.16, so YD Bio Ordinary Shares's price volatility has been higher than the market average.

Beta	0.16
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.11
Average Volume (20 Days)	129,079

Income Statement

In the last 12 months, YD Bio Ordinary Shares had revenue of 510.36K and earned -1.41M in profits. Earnings per share was -0.56.

Revenue	510.36K
Gross Profit	155.36K
Operating Income	-1.46M
Net Income	-1.41M
EBITDA	-1.28M
EBIT	-1.39M
Earnings Per Share (EPS)	-0.56

Full Income Statement

Balance Sheet

The company has 3.13M in cash and 22.55K in debt, giving a net cash position of 3.11M.

Cash & Cash Equivalents	3.13M
Total Debt	22.55K
Net Cash	3.11M
Retained Earnings	-1.93M
Total Assets	2.95M
Working Capital	-11.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.84M and capital expenditures -2.91M, giving a free cash flow of -4.75M.

Operating Cash Flow	-1.84M
Capital Expenditures	-2.91M
Free Cash Flow	-4.75M
FCF Per Share	-1.15

Full Cash Flow Statement

Margins

Gross margin is 30.44%, with operating and profit margins of -286.45% and -276.58%.

Gross Margin	30.44%
Operating Margin	-286.45%
Pretax Margin	-271.67%
Profit Margin	-276.58%
EBITDA Margin	-250.99%
EBIT Margin	-286.45%
FCF Margin	-930.29%

Dividends & Yields

YDES does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for YDES.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	24.72
Piotroski F-Score	2